CBM’s integrated approach provides high quality and consistent end-to-end manufacturing capability including: Process and Analytical Development Plasmid DNA production Viral Vector Production of Lentivirus AAV and Adenovirus Testing and Analytics Autologous, Allogeneic and Gene-edited Cell Therapy Bioprocessing and Cell banking. Our comprehensive service offering accelerates speed to market through supply chain disruption mitigation strategies, end-to-end program management expertise and unique platform technology with the ability to follow a molecule from idea to commercialization. The Center for Breakthrough Medicines is on track to be the largest single-site cell and gene therapy contract development and manufacturing organization in the world.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |